HCP, Inc. (HCP) Given Average Recommendation of “Buy” by Brokerages

HCP, Inc. (NYSE:HCP) has been given an average recommendation of “Buy” by the sixteen brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $30.29.

A number of analysts recently commented on the company. Morgan Stanley set a $32.00 price target on HCP and gave the stock a “hold” rating in a research note on Thursday, March 28th. TheStreet raised shares of HCP from a “c” rating to a “b-” rating in a report on Wednesday, February 13th. Scotiabank began coverage on shares of HCP in a research note on Monday, December 10th. They issued an “outperform” rating and a $32.00 price target on the stock. BMO Capital Markets upgraded shares of HCP from a “market perform” rating to an “outperform” rating and raised their price target for the company from $30.00 to $33.00 in a research note on Wednesday, January 9th. Finally, Robert W. Baird upgraded shares of HCP from a “neutral” rating to an “outperform” rating in a research note on Monday, January 7th.

Shares of NYSE:HCP traded down $0.18 during trading on Thursday, reaching $31.05. 2,596,663 shares of the company traded hands, compared to its average volume of 3,262,320. The firm has a market cap of $14.93 billion, a PE ratio of 17.06, a price-to-earnings-growth ratio of 7.79 and a beta of 0.46. HCP has a 52-week low of $21.80 and a 52-week high of $32.23. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.64 and a current ratio of 0.64.

HCP (NYSE:HCP) last released its quarterly earnings data on Wednesday, February 13th. The real estate investment trust reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $1.30. HCP had a return on equity of 18.40% and a net margin of 57.41%. The firm had revenue of $441.92 million during the quarter, compared to analyst estimates of $445.81 million. During the same quarter in the prior year, the firm posted $0.48 earnings per share. The business’s quarterly revenue was down .3% compared to the same quarter last year. Research analysts predict that HCP will post 1.74 EPS for the current year.

A number of institutional investors have recently bought and sold shares of HCP. AXA boosted its stake in shares of HCP by 8.4% during the 3rd quarter. AXA now owns 37,813 shares of the real estate investment trust’s stock valued at $995,000 after buying an additional 2,936 shares during the period. Janus Henderson Group PLC raised its holdings in shares of HCP by 16.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,008,528 shares of the real estate investment trust’s stock valued at $26,548,000 after purchasing an additional 139,214 shares in the last quarter. American International Group Inc. raised its holdings in shares of HCP by 4.8% during the 3rd quarter. American International Group Inc. now owns 236,738 shares of the real estate investment trust’s stock valued at $6,231,000 after purchasing an additional 10,857 shares in the last quarter. Shell Asset Management Co. raised its holdings in shares of HCP by 30.3% during the 3rd quarter. Shell Asset Management Co. now owns 37,121 shares of the real estate investment trust’s stock valued at $977,000 after purchasing an additional 8,641 shares in the last quarter. Finally, Pictet Asset Management Ltd. raised its holdings in shares of HCP by 2.2% during the 3rd quarter. Pictet Asset Management Ltd. now owns 283,011 shares of the real estate investment trust’s stock valued at $7,449,000 after purchasing an additional 6,200 shares in the last quarter. Hedge funds and other institutional investors own 95.64% of the company’s stock.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Story: The role of implied volatility with call option volume

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.